Literature DB >> 11435815

Multiple endocrine neoplasia type 1 and adrenal lesions.

L Barzon1, C Pasquali, C Grigoletto, S Pedrazzoli, M Boscaro, F Fallo.   

Abstract

PURPOSE: We investigated the relationship of long-term pancreatic hormone hypersecretion with adrenal lesions in patients with multiple endocrine neoplasia type 1 and in those with sporadic pancreatic endocrine tumors.
MATERIALS AND METHODS: We assessed the prevalence of adrenal lesions in 20 patients with multiple endocrine neoplasia type 1 and in a control group of 12 with sporadic pancreatic endocrine tumors. We also performed genetic testing for germline mutations of MEN1, the multiple endocrine neoplasia type 1 gene.
RESULTS: Adrenal lesions were common in multiple endocrine neoplasia type 1, accounting for 35% of cases. All adrenal lesions were nonfunctioning and benign. The relative risk of adrenal tumors was higher in patients with multiple endocrine neoplasia type 1 than in controls (p <0.05). No apparent relationship was observed of hormonal pattern or genotype with adrenal disease.
CONCLUSIONS: Hormone hypersecretion by pancreatic endocrine tumors is not the primary cause of the development of adrenal lesions and the role of the MEN1 gene in adrenal tumorigenesis remains unclear. Adrenal lesions follow a benign course in most multiple endocrine neoplasia type 1 cases but careful morphological and functional followup is advisable.

Entities:  

Mesh:

Year:  2001        PMID: 11435815

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  MEN1 family with a novel frameshift mutation.

Authors:  V Nuzzo; L Tauchmanová; A Falchetti; A Faggiano; F Marini; S Piantadosi; M L Brandi; L Leopaldi; A Colao
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 2.  Care for patients with multiple endocrine neoplasia type 1: the current evidence base.

Authors:  C R C Pieterman; M R Vriens; K M A Dreijerink; R B van der Luijt; G D Valk
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

3.  The early diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a case report.

Authors:  G Tamagno; E De Carlo; C Martini; D Rubello; F Fallo; N Sicolo
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

4.  Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value.

Authors:  Jens Waldmann; Volker Fendrich; Nils Habbe; Detlef K Bartsch; Emily P Slater; Peter H Kann; Matthias Rothmund; Peter Langer
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

5.  Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening.

Authors:  J Waldmann; D K Bartsch; P H Kann; V Fendrich; M Rothmund; P Langer
Journal:  Langenbecks Arch Surg       Date:  2007-01-19       Impact factor: 2.895

6.  Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene.

Authors:  John E Griniatsos; Nikoletta Dimitriou; Athanassios Zilos; Stratigoula Sakellariou; Konstantinos Evangelou; Smaragda Kamakari; Penelope Korkolopoulou; Gregory Kaltsas
Journal:  World J Surg Oncol       Date:  2011-01-25       Impact factor: 2.754

Review 7.  Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review.

Authors:  Vajihe Chavoshi; Seyed Saeed Tamehri Zadeh; Shayesteh Khalili; Amirhassan Rabbani; Seyed Amir Hassan Matini; Zhaleh Mohsenifar; Farzad Hadaegh
Journal:  BMC Endocr Disord       Date:  2022-04-21       Impact factor: 3.263

Review 8.  A MEN1 Patient Presenting With Multiple Parathyroid Adenomas and Transient Hypercortisolism: A Case Report and Literature Review.

Authors:  Fuqiong Chen; Qinqin Xu; Wenzhu Yue; Xuefeng Yu; Shiying Shao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

Review 9.  Multiple endocrine neoplasia type I.

Authors:  Rasa Zarnegar; Laurent Brunaud; Orlo H Clark
Journal:  Curr Treat Options Oncol       Date:  2002-08

10.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.